Gene-level analysis of variant prevalence revealed no significant enrichment of PLP variants in specific genes when comparing the healthy individuals (4 for BRCA1, 6 for BRCA2) and cancer patients (8 for BRCA1, 12 for BRCA2) (Fisher’s Exact P = 0.745). This evidence concerns the gene BRCA1 and cancer.